Autism – Can Stem Cell Therapy Cure the Disability?

  • Post author:
  • Post category:Business

Among the many exciting therapeutic advances are the use of stem cell (SC) therapy. It involves the use of SCs implanted in sick patients to help repair or repair dysfunctional organs.
The science of SCl is not limited to the treatment of illness. In fact, SC is used to study disease models, develop new drugs, and study side effects of drugs.

This revolution is coming at a good time as the baby boomer population ages, the cost of providing medical care increases, and the availability of medicines to control aging-related illnesses is inadequate. .. The cost of bringing a new drug to market and the associated time frame are almost affordable. Given the firewalls established between pharmaceutical companies and professionals, the outlook for pharmaceutical and biotechnology companies is bleak.
The costs associated with biotherapy far outweigh the costs of developing “chemical” drugs. And the fact is that developed countries already have de facto care rations.

SC therapy, on the other hand, does not require reinventing the wheel. Autologous SC therapy is now available. Quality control is required by FDA investigations.

The question is: Do I need to use other CS options such as Initial CS? The answer here is that fascinating ethical and religious dissent remains a major obstacle to their end use.
Induced pluripotent SCs, adult cell-derived SCs, are intriguing but still in the developmental stage. These cells behave like embryonic SCs, but unfortunately there are still some “bugs” that need to be fixed.

How is SC manufactured? Although the autologous model is currently satisfactory, it is beneficial to have the option of providing ready-to-use access without exposing the stem cell center scottsdale patient to invasive procedures involving harvesting. Quality control, consistency, and safety remain concerns. This makes it difficult to facilitate access to clinical trials using CS. The process of getting a grant from a federal agency such as the National Institutes of Health is difficult and tedious. Academic centers may have the time and effort to follow this path, but frontline doctors do not.

Another issue is related to external access to the SC. To be honest, foreign facilities do not have quality control. The appeal of medical tourism is related to easy access to suspicious products and services and low cost. It is imperative that the Stem Cell Therapy Center engage in scientific research involving rigorous measurement of standards, adherence to good clinical practices, and measurement of improvement.

Our center is actively working on the evaluation of autologous SC therapy for osteoarthritis. It is important to accurately measure both subjective and objective data. The first report from our center has been published.
Read below for more information.

(Wei N, Beard S, Delauter S, Bitner C, Gillis R, Rau L, Miller C, Clark T. Guided mesenchymal stem cell stratification technique for the treatment of knee osteoarthritis. J Res Applied 2011; 11: 44-48)